Erratum: Stylopine: A potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy

Frontiers in Pharmacology
2023.0

Abstract

[This corrects the article DOI: 10.3389/fphar.2023.1150270.]. CI - Copyright (c) 2023 and Frontiers Production Office. CN - Frontiers Production Office LA - eng PT - Published Erratum DEP - 20230505 PL - Switzerland TA - Front Pharmacol JT - Frontiers in pharmacology JID - 101548923 EFR - Front Pharmacol. 2023 Mar 28;14:1150270. doi: 10.3389/fphar.2023.1150270. PMID: 37056983 PMC - PMC10196444 OTO - NOTNLM OT - MG-63 OT - VEGFR2 OT - benzylisoquinoline alkaloids OT - osteosarcoma OT - stylopine EDAT- 2023/05/22 19:11 MHDA- 2023/05/22 19:12 PMCR- 2023/05/05 CRDT- 2023/05/22 12:12 PHST- 2023/04/27 00:00 [received] PHST- 2023/04/27 00:00 [accepted] PHST- 2023/05/22 19:12 [medline] PHST- 2023/05/22 19:11 [pubmed] PHST- 2023/05/22 12:12 [entrez] PHST- 2023/05/05 00:00 [pmc-release]

Knowledge Graph

Similar Paper